Pay in 4 interest-free payments of $5.22 Learn more
Ships within 48 hours · Estimated delivery Aug 24 - Aug 29
By increasing the effect of this hormone, GLP-1 weight loss medications improve glycemic control and help patients feel full after eating less
Boumendjel 2011)
Tirzepatide is a novel glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist licensed in the UK for the treatment of type 2 diabetes mellitus and, more recently, for chronic weight management in adults with obesity or overweight with weight-related comorbidities, as per the MHRA Summary of Product Characteristics
Low blood sugar can also occur, especially if insulin or certain other diabetes medications are used at the same time
US$ 21.64
US$ 25.56
US$ 22.22
US$ 23.98
US$ 29.09
US$ 28.80
US$ 21.42
US$ 26.59
US$ 22.84
US$ 23.45
US$ 29.51
